Affimed N.V. announced the appointment of Dr. Wolfgang Fischer as Chief Operating Officer. Dr. Fischer brings to the company 20 years of experience in research and drug development with a focus on oncology, immunology and pharmacology. He joins the company from Sandoz Biopharmaceuticals (Novartis Group), where he managed the development and registration of Sandoz' biosimilar pipeline assets since 2012 and served as Global Head of Program and Project Management since 2014.